Dhjj Financial Advisors, Ltd. Biogen Inc. Transaction History
Dhjj Financial Advisors, Ltd.
- $214 Million
- Q2 2024
A detailed history of Dhjj Financial Advisors, Ltd. transactions in Biogen Inc. stock. As of the latest transaction made, Dhjj Financial Advisors, Ltd. holds 23 shares of BIIB stock, worth $4,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 24
4.17%
Holding current value
$4,249
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,049Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.07 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$3.02 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.69 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.31 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$1.05 Billion0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $26.6B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...